I understand that he was referencing SALES .... it just seems to me that a necessary condition for the sales of a technology are that the technology is developed, that the manufacturing community uses said technology and that the package within which the technology is delivered is accepted.
Given that large scale and medium scale production runs of high value metal printed parts has not actually gained traction, how reasonable is it to evaluate the technology Sigma Labs offers in terms of SALES and REVENUES? It seems to me that to determine the value of Sigma at the current time on sales or sales growth quarter over quarter or year over year at the current time is a strategy that will miss the value because the value is in the technology - IF ACCEPTED.
a stretch, but... go back to the late 1800's in Germany....Daimler, Maybach, Benz and others were working on internal combustion engine horseless carriages...in say 1885 would increasing sales figures have best represented the value of the horseless carriage manufacturers for investors...or would you have put your cash into buggy whip manufacturers at that time?
investing for future value ... or .... trading for today Where you start that analysis will be determinative of your conclusion.
I am in for the long haul here. I believe that the current sales are strictly limited by the industry to those companies now leading the testing process for additively produced parts. At the current moment there are no industry standards - There are no government standards - The are no insurance company standards - for the in-process qualification of parts built with additive technology.
I believe that the network of connections between Sigma and the other current players in the field of DEVELOPING ADDITIVE MANUFACTURING TECHNIQUES AND STANDARDS is a form of consensual validation of Sigma Labs and the technology Mark et al are developing. If you want to wait to be able to justify holding Sigma Labs on the basis of fundamental analysis of business value as it relates to the pps of said business, fine and good. IF that is your approach. On the other hand, IF your focus is to include the expectations and risks involved in the development of a newly developing technology which has NO FUNDAMENTAL reason to be widely accepted at the current time given the state of the industry and technology, then you might well have a different valuation of Sigma's pps which does not limit itself to the absolute value of sales, or sales Q over Q or Yover Y.
patience and GLTA
